• Wrong document? Swap it for free
  • Written by students who passed
  • Immediately available after payment
  • Read online or as PDF
Sell
Where do you study
Your language
Document preview thumbnail
Preview 4 out of 62 pages
Exam (elaborations)

NRNP 6630 Week 8 Assignment Practice Exam | 120 Psychopharmacology Questions with Answers and Rationales

Document preview thumbnail
Preview 4 out of 62 pages

NRNP 6630 Week 8 Assignment Practice Exam | 120 Psychopharmacology Questions with Answers and Rationales Foundations of pharmacology 1. What does oral bioavailability describe? A. The fraction of a dose reaching systemic circulation unchanged B. The maximal receptor response C. The fraction bound to receptors D. The time required for renal elimination 2. A drug follows first-order elimination. What remains after four half-lives with no additional doses? A. 6.25% B. 25% C. 50% D. 0% 3. Which variable most directly determines a loading dose for a target plasma concentration? A. Elimination rate alone B. Renal clearance alone C. Dosing interval alone D. Volume of distribution 4. Which variable most directly determines the maintenance dose rate at a target steady-state concentration? A. Clearance B. Volume of distribution alone C. Receptor affinity alone D. Tablet color 5. With linear kinetics, approximately when is steady state approached during repeated dosing? A. Only after drug discontinuation B. After four to five half-lives C. After exactly 24 hours for every drug D. After one dose for every drug 6. A strong CYP inhibitor is added to an active drug primarily metabolized by that enzyme. What is the likely result? A. Reduced absorption in every case B. Increased drug exposure C. Increased clearance D. Guaranteed loss of efficacy

Content preview

NRNP 6630 Week 8 Assignment Practice Exam | 120
Psychopharmacology Questions with Answers and
Rationales

Foundations of pharmacology

1. What does oral bioavailability describe?
A. The fraction of a dose reaching systemic circulation unchanged
B. The maximal receptor response
C. The fraction bound to receptors
D. The time required for renal elimination

2. A drug follows first-order elimination. What remains after four half-lives with no
additional doses?
A. 6.25%

B. 25%

C. 50%

D. 0%



3. Which variable most directly determines a loading dose for a target plasma
concentration?
A. Elimination rate alone
B. Renal clearance alone
C. Dosing interval alone
D. Volume of distribution

4.Which variable most directly determines the maintenance dose rate at a
target steady-state concentration?
A. Clearance

B. Volume of distribution alone
C. Receptor affinity alone
D. Tablet color


1

,5. With linear kinetics, approximately when is steady state approached during
repeated dosing?
A. Only after drug discontinuation
B. After four to five half-lives
C. After exactly 24 hours for every drug
D. After one dose for every drug

6.A strong CYP inhibitor is added to an active drug primarily metabolized by that
enzyme. What is the likely result?
A. Reduced absorption in every case
B. Increased drug exposure
C. Increased clearance
D. Guaranteed loss of efficacy




2

,7. What can a strong enzyme inducer do to an active substrate drug?
A. Prevent renal excretion
B. Increase receptor affinity
C. Immediately eliminate all adverse effects
D. Lower its plasma concentration

8. Which finding indicates a narrow therapeutic index?
A. All patients require the same dose
B. The drug has no interactions
C. Toxic doses are close to effective doses
D. The drug is always safe in pregnancy

9. A reversible competitive antagonist typically causes which concentration-response
change?
A. A rightward shift with preserved maximal response if enough agonist is given
B. A permanently increased maximal response
C. A leftward shift with increased potency
D. Irreversible receptor destruction

10. An older adult has reduced renal function. Which prescribing principle is most
appropriate?
A. Use age alone to double the dose
B. Assume normal clearance if creatinine appears normal
C. Assess drug-specific renal dosing and monitor response
D. Avoid every medication

Core psychiatric medication safety

11. What should patients expect when starting an SSRI for depression?
A. Immediate dependence after one dose
B. Full remission within one hour
C. Therapeutic benefit usually develops over several weeks
D. No need for follow-up
3

, 12.A patient taking sertraline and tramadol develops agitation, diaphoresis, and
clonus. What is the likely syndrome?
A. Uncomplicated opioid withdrawal only
B. Iron overload
C. Primary hypothyroidism
D. Serotonin syndrome




4

Document information

Uploaded on
October 2, 2026
Number of pages
62
Written in
2026/2027
Type
Exam (elaborations)
Contains
Questions & answers
$17.49

Wrong document? Swap it for free Within 14 days of purchase and before downloading, you can choose a different document. You can simply spend the amount again.
Written by students who passed
Immediately available after payment
Read online or as PDF

Seller avatar
Reputation scores are based on the amount of documents a seller has sold for a fee and the reviews they have received for those documents. There are three levels: Bronze, Silver and Gold. The better the reputation, the more your can rely on the quality of the sellers work.
paulhans
3.5
(136)
Sold
802
Followers
641
Items
8147
Last sold
2 weeks ago



Why students choose Stuvia

Created by fellow students, verified by reviews

Quality you can trust: written by students who passed their tests and reviewed by others who've used these notes.

Didn't get what you expected? Choose another document

No worries! You can instantly pick a different document that better fits what you're looking for.

Pay as you like, start learning right away

No subscription, no commitments. Pay the way you're used to via credit card and download your PDF document instantly.

Student with book image

“Bought, downloaded, and aced it. It really can be that simple.”

Alisha Student

Working on your references?

Create accurate citations in APA, MLA and Harvard with our free citation generator.

Working on your references?

Frequently asked questions